Sage Therapeutic Stock Technical Analysis
| SAGE Stock | USD 5.47 0.08 1.44% |
As of the 30th of November, Sage Therapeutic has the Variance of 22.17, risk adjusted performance of (0.06), and Coefficient Of Variation of (1,075). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Sage Therapeutic, as well as the relationship between them. Please validate Sage Therapeutic standard deviation, treynor ratio, as well as the relationship between the Treynor Ratio and potential upside to decide if Sage Therapeutic is priced more or less accurately, providing market reflects its prevalent price of 5.47 per share. Given that Sage Therapeutic has information ratio of (0.12), we advise you to double-check Sage Therapeutic's current market performance to make sure the company can sustain itself at a future point.
Sage Therapeutic Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Sage, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to SageSage |
Sage Therapeutic Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 25.71 | Buy | 20 | Odds |
Most Sage analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Sage stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Sage Therapeutic, talking to its executives and customers, or listening to Sage conference calls.
Sage Therapeutic technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Sage Therapeutic Technical Analysis
The output start index for this execution was ten with a total number of output elements of fifty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Sage Therapeutic volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Sage Therapeutic Trend Analysis
Use this graph to draw trend lines for Sage Therapeutic. You can use it to identify possible trend reversals for Sage Therapeutic as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Sage Therapeutic price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Sage Therapeutic Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Sage Therapeutic applied against its price change over selected period. The best fit line has a slop of 0.04 , which may suggest that Sage Therapeutic market price will keep on failing further. It has 122 observation points and a regression sum of squares at 61.09, which is the sum of squared deviations for the predicted Sage Therapeutic price change compared to its average price change.About Sage Therapeutic Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Sage Therapeutic on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Sage Therapeutic based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Sage Therapeutic price pattern first instead of the macroeconomic environment surrounding Sage Therapeutic. By analyzing Sage Therapeutic's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Sage Therapeutic's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Sage Therapeutic specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2022 | 2023 | 2024 (projected) | Graham Number | 63.5 | 52.16 | 36.38 | Receivables Turnover | 0.56 | 1.02 | 1.08 |
Sage Therapeutic November 30, 2024 Technical Indicators
Most technical analysis of Sage help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Sage from various momentum indicators to cycle indicators. When you analyze Sage charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | (0.21) | |||
| Mean Deviation | 3.21 | |||
| Coefficient Of Variation | (1,075) | |||
| Standard Deviation | 4.71 | |||
| Variance | 22.17 | |||
| Information Ratio | (0.12) | |||
| Jensen Alpha | (0.71) | |||
| Total Risk Alpha | (1.23) | |||
| Treynor Ratio | (0.22) | |||
| Maximum Drawdown | 30.67 | |||
| Value At Risk | (6.27) | |||
| Potential Upside | 6.39 | |||
| Skewness | (1.83) | |||
| Kurtosis | 8.7 |
Sage Therapeutic November 30, 2024 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Sage stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 10,032 | ||
| Daily Balance Of Power | (0.47) | ||
| Rate Of Daily Change | 0.99 | ||
| Day Median Price | 5.51 | ||
| Day Typical Price | 5.49 | ||
| Price Action Indicator | (0.08) |
Complementary Tools for Sage Stock analysis
When running Sage Therapeutic's price analysis, check to measure Sage Therapeutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sage Therapeutic is operating at the current time. Most of Sage Therapeutic's value examination focuses on studying past and present price action to predict the probability of Sage Therapeutic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sage Therapeutic's price. Additionally, you may evaluate how the addition of Sage Therapeutic to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |